AI Article Synopsis

  • * The study compared taurocholate uptake in rat and human hepatocytes and found that rat cells showed a significant decrease in uptake and a shift in transport patterns after 72 hours.
  • * In contrast, 5-day-old human hepatocytes maintained better taurocholate uptake capabilities and were more effectively inhibited by drugs, suggesting they provide a more reliable model for studying drug interactions.

Article Abstract

Bile salt transport across hepatocytes requires a coordinate action of transporters, which is thought to be a target for drug-induced cholestasis. Hepatocytes provide the most competent in vitro model to predict transporter-related toxic drug effects. The aim of this study was to show a correlation between inhibitory potential of drugs and the change of rate, as well as of the active to passive ratio of taurocholate uptake in these cells. In rat hepatocytes, along with a significant decrease of uptake (86.4% by 72h), and the shift of saturable/unsaturable transport (from 92/8 to 55/45 in a 24-72h time interval), the efficacy of taurocholate uptake inhibition was highly reduced (IC(50) cyclosporin A 3.9 to >100μM, and bosentan 9.1-49.8μM at 1 and 72h, respectively). In contrast, 5-day-old human hepatocytes preserved 70% of their taurocholate uptake capacity with a 2-fold higher active than passive transport, which resulted in a more efficient inhibition by drugs (IC(50) cyclosporin A, 2.4 to ∼10μM and bosentan 28.9-45.5μM at 1h and 5days, respectively). Our results support that reliable drug interaction studies might be performed in 5-day-old human hepatocyte cultures, while experiments using rat hepatocytes at more than 24h after seeding will highly underestimate the probability of drug interaction.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tiv.2011.11.005DOI Listing

Publication Analysis

Top Keywords

taurocholate uptake
16
rat hepatocytes
12
active passive
8
ic50 cyclosporin
8
5-day-old human
8
drug interaction
8
hepatocytes
6
uptake
5
differential inhibitory
4
inhibitory cyclosporin
4

Similar Publications

Article Synopsis
  • * This study investigated the glucose transporter CsGTP4 in C. sinensis to better understand how the parasite uptakes nutrients, using Xenopus laevis oocytes for experimentation.
  • * Findings showed that CsGTP4 facilitates deoxy-D-glucose uptake in a precise manner that is independent of sodium, with specific kinetics, and is inhibited by glucose and galactose, which can inform the development of new antiparasitic treatments.
View Article and Find Full Text PDF

Fluorophore-coupled bile acids (BA) represent an important tool for intravital analysis of BA flux in animal models of cholestatic diseases. However, addition of a fluorophore to a BA may alter transport properties. We developed and validated a 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole-coupled taurocholic acid (3β-NBD-TCA) as a probe for intravital analysis of BA homeostasis.

View Article and Find Full Text PDF

Novel NTCP ligand dimeric bile acid conjugated with ASO reduce hepatitis B virus surface antigen in vivo.

Eur J Med Chem

December 2024

State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, 222 S. Tianshui Rd., Lanzhou, 730000, PR China; SicaGene Biotechnology Co., Ltd, Buiding 16, No. 9 Yongteng North Road, Haidian District, Beijing, 100144, PR China. Electronic address:

Hepatitis B virus (HBV) specifically infects hepatocytes and causes severe liver diseases. However, functional cure is rarely attainable by current treatment modalities. Anti-sense oligonucleotide (ASO), which targets pregenomic RNAs to reduce hepatitis B virus (HBV) antigen production and viral replication, has been studied as a novel treatment strategy for HBV cure and can be conjugated with N-acetylgalactosamine (GalNAc), thereby enhancing hepatocyte uptake via the asialoglycoprotein receptor (ASGPR).

View Article and Find Full Text PDF
Article Synopsis
  • - The study addresses the limitations of traditional drug delivery by using l-carnitine and a targeted peptide to enhance the delivery of silybin specifically to liver cells, minimizing side effects from nonspecific delivery.
  • - Liposomes modified with these agents showed improved uptake in liver cells, with up to 2.36 μg/mg of coumarin-6 captured compared to only 1.05 μg/mg in unmodified liposomes.
  • - The targeted liposome formulations were tested in mice, resulting in a significantly higher concentration and longer retention time of silybin in the liver, indicating their potential for more effective liver disease treatment.
View Article and Find Full Text PDF

Vitamin D and cholesterol share the same intestinal transporters. Thus, it was hypothesized that dietary cholesterol adversely affects vitamin D uptake. The current studies investigated the influence of cholesterol on the availability of oral vitamin D.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

A PHP Error was encountered

Severity: Notice

Message: fwrite(): Write of 34 bytes failed with errno=28 No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 272

Backtrace:

A PHP Error was encountered

Severity: Warning

Message: session_write_close(): Failed to write session data using user defined save handler. (session.save_path: /var/lib/php/sessions)

Filename: Unknown

Line Number: 0

Backtrace: